All Stories

  1. Developmental delay in attaining adult levels of motor excitability in children and adolescents with Tourette syndrome: a mega-analysis study
  2. Doxycycline, Schizophrenia, and Toxoplasmosis
  3. Tourette experts do care about complementary medicine . . .
  4. Talking to the doctor reduces tics more than trying not to tic
  5. Correlating clinical course with baseline subcortical shape in provisional tic disorder
  6. Diagnostic Criteria for Primary Tic Disorders: More Reappraisal
  7. Tourette syndrome research highlights from 2023
  8. What's new with tics and Tourette's? Highlights from 2023.
  9. Tics that started recently usually get better but almost never go away completely.
  10. Tics in ADHD
  11. Network Localization of Brain Stimulation Targets for Trait Anxiety
  12. Tourette syndrome research highlights from 2022
  13. Door-To-Door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  14. Smoke gets in your tics
  15. Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders
  16. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
  17. Early‐Life and Family Risk Factors for Tic Disorder Persistence into Adulthood
  18. Tics in ADHD
  19. Finding reviewer suggestions for multi-author papers
  20. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  21. Editorial: Recent advances in understanding Tourette syndrome, tic disorders and functional tics
  22. Smoke gets in your tics
  23. Will people buzz their wrist in their daily life to help their tics?
  24. Testing whether median nerve stimulation helps tics by the mechanism we thought it did
  25. Tics in ADHD
  26. Suggestions for new NIH grant applicants
  27. Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial
  28. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  29. TikTok Tourette’s: Are We Witnessing a Rise in Functional Tic-Like Behavior Driven by Adolescent Social Media Use?
  30. Tic prevalence by direct observation in an elementary school
  31. Tourette syndrome research highlights from 2021
  32. Diagnosis and Management of Functional Tic-Like Phenomena
  33. Door-to-door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  34. Why Tic Severity Changes from Then to Now and from Here to There
  35. 3.122 Open Trial of Median Nerve Stimulation for the Treatment of Tourette’s Disorder
  36. 13.2 Predictors of Tic Symptom Evolution After First Onset
  37. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  38. Median nerve stimulation for treatment of tics: A 4-week, open trial with ecological momentary assessment
  39. TikTok Tourette's: are we witnessing a rise in neurological conditions driven by adolescent social media use?
  40. Why tic severity changes from then to now and from here to there
  41. The start of the biggest brain imaging and genetics study ever in Tourette syndrome
  42. Finding reviewer suggestions for multi-author papers
  43. Optimal timing for lithium levels
  44. Tourette syndrome research highlights from 2021
  45. Tourette syndrome research highlights from 2020
  46. Neurobiology and Functional Anatomy of Tic Disorders
  47. The timing of tics is fractal, even in the first few months of a tic disorder
  48. Tourette syndrome research highlights from 2020
  49. Treatment failure in persistent tic disorders: an expert clinicians’ consensus-based definition
  50. Predicting Clinical Course from Subcortical Shape in Provisional Tic Disorder
  51. Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
  52. Recent progress on Tourette syndrome
  53. A Comprehensive Review of Tic Disorders in Children
  54. What happens to tic disorders over time?
  55. "I can hold my tics back for a while. What does that tell me?"
  56. TicTimer Web: software for measuring tic suppression remotely
  57. Electronic medical records need to accommodate confidentiality for presymptomatic testing
  58. The Child with Tics or Other Common Movement Disorders
  59. Tourette syndrome research highlights from 2019
  60. Course of tic disorders over the lifespan
  61. Tourette syndrome research highlights from 2019
  62. TicTimer Web: software for measuring tic suppression remotely
  63. Correlates and clinical implications of tic suppressibility
  64. Size of hippocampus predicts improvement in children with recent-onset tics
  65. Phonic tics and one motor tic? Call it Tourette syndrome.
  66. Can we measure Parkinson disease severity with levodopa and MRI?
  67. Age-dependent differences in functional brain networks are atypical in Tourette syndrome
  68. In obesity, pictures of high-calorie food elicit dopamine release equally when hungry or full.
  69. Hippocampal volume in Provisional Tic Disorder predicts tic severity at 12-month follow-up
  70. What happens to children with recent-onset tics, and why?
  71. Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease
  72. 2.54 EXPLORING BEHAVIORAL MARKERS PREDICTING ONE-YEAR TIC OUTCOME IN CHILDREN WITH RECENT-ONSET TICS
  73. Treating depression in epilepsy: a controlled trial
  74. The urge to blink in Tourette syndrome
  75. Tourette syndrome research highlights from 2018
  76. Atypical Functional Connectivity In Tourette Syndrome differs between Children and Adults
  77. Tic Suppression in Children With Recent-Onset Tics Predicts 1-Year Tic Outcome
  78. In Provisional Tic Disorder, better tic suppression predicts better prognosis
  79. Provisional Tic Disorder is not so transient
  80. Correction: Brain structure in pediatric Tourette syndrome
  81. Ziprasidone may have a role in treating psychosis in Parkinsonian disease
  82. The urge to blink in Tourette syndrome
  83. How to switch to pimavanserin from an older antipsychotic for psychosis in Parkinson's disease
  84. Atypical Functional Connectivity in Tourette Syndrome Differs Between Children and Adults
  85. Transient tics aren't: Outcome of recent-onset tic disorder at one year
  86. Testing a new (D1) dopamine blocking strategy to treat Tourette syndrome in children
  87. TicTrainer software
  88. Research on tic disorders from 2017
  89. Effects of DBS in dorsal vs. ventral STN
  90. Who can suppress tics best?
  91. Tourette Syndrome
  92. TicTimer software for measuring tic suppression
  93. TicTrainer web software for tic suppression training
  94. Tourette syndrome research highlights from 2016
  95. Patterns and predictors of tic suppressibility in youth with tic disorders
  96. 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder
  97. TicTimer: software for measuring tic suppression
  98. Tourette syndrome research highlights from 2016
  99. Mapping movement, mood, motivation, and mentation in the subthalamic nucleus
  100. A Case of Apparent Upper-Body Freezing in Parkinsonism while Using a Wheelchair
  101. What creates the urge to tic in Tourette syndrome?
  102. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia
  103. Brain structure in pediatric Tourette syndrome
  104. VISIT-TS: A multimedia tool for population studies on tic disorders
  105. A picture is worth 1000 words: a new tool for Tourette studies
  106. Tourette syndrome research highlights 2015
  107. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status
  108. Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D 2 Receptor Binding and Age in Obesity
  109. Brain structure in pediatric Tourette syndrome
  110. When do tics turn into Tourette syndrome?
  111. Return of QuanDyn(TM)
  112. Designing MRI studies of children with neuropsychiatric disorders
  113. Machine learning "diagnosis" of Tourette syndrome by resting brain activity
  114. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  115. Safety of i.v. L-DOPA
  116. Automated training to hold still
  117. A review session can raise medical student scores on the psychiatry shelf exam
  118. Impact of a structured review session on medical student psychiatry subject examination performance
  119. Stand up for i.v. levodopa!
  120. Brain imaging in Tourette's, 2014-2015
  121. Safety of i.v. L-DOPA (preprint)
  122. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  123. Tourette Syndrome research highlights 2014
  124. Brain dopamine pathways influence emotional eating
  125. Rapid quantitative pharmacodynamic imaging with Bayesian estimation
  126. Whole-brain blood flow correction in ASL
  127. Tourette Syndrome research highlights 2014
  128. Kids can suppress tics early on--if the price is right
  129. Levodopa effects on [11C]raclopride binding in the resting human brain
  130. Tics
  131. Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI
  132. F1000Research: Tics welcomes you to 21st century biomedical publishing
  133. Intro to special issue on Tourette syndrome
  134. Current anxiety disorder affects mood response to STN DBS in PD
  135. A revised method for measuring distraction by tactile stimulation
  136. Anatomical location in STN matters for DBS in Parkinson's
  137. Insulin, dopamine D2 receptors, and monetary reward discounting: A common pathway for food and drug addiction
  138. Developmental Changes in the Organization of Functional Connections between the Basal Ganglia and Cerebral Cortex
  139. Spatial Reorganization of Putaminal Dopamine D2-Like Receptors in Cranial and Hand Dystonia
  140. Levodopa-stimulated dopamine release in Tourette syndrome
  141. A within-subject comparison of seizure duration with etomidate and methohexital in electroconvulsive therapy
  142. Prolactin and fMRI response to SKF38393 in the baboon
  143. Automatic size and shape measurements of deep brain structures in Tourette syndrome
  144. Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle
  145. Towards objectively quantifying sensory hypersensitivity: a pilot study of the “Ariana effect”
  146. Olanzapine for psychosis in Parkinson disease
  147. Neurobiology and Functional Anatomy of Tic Disorders
  148. A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol
  149. NMB PET outside the striatum
  150. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
  151. Mood Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
  152. Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
  153. A New (Old) Treatment Option for Depression in Parkinson's Disease
  154. Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours
  155. Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (TSfMRI)
  156. A Perfusion MRI Study of Emotional Valence and Arousal in Parkinson’s Disease
  157. Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
  158. Tics
  159. Deep brain stimulation for Tourette syndrome
  160. Hippocampal Volumes in Youth With Type 1 Diabetes
  161. Neuroimaging in Baboons
  162. Cerebral Mitochondrial Metabolism in Early Parkinson's Disease
  163. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
  164. Psychiatric screening for DBS
  165. The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association
  166. Regional Brain Volume Differences Associated With Hyperglycemia and Severe Hypoglycemia in Youth With Type 1 Diabetes
  167. Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome
  168. Intravenous levodopa administration in humans based on a two-compartment kinetic model
  169. The Value of Quantitative Electroencephalography in Clinical Psychiatry: A Report by the Committee on Research of the American Neuropsychiatric Association
  170. Repetitive and impulsive behaviors in treated Parkinson disease
  171. II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance
  172. Sex, Lies, and Neuroimaging
  173. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
  174. Brain Stimulation in Psychiatric Treatment
  175. Blood Flow Imaging of the Brain: 50 Years Experience
  176. Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
  177. Pathophysiology of parkinsonism due to hydrocephalus
  178. Dopaminergic modulation of response inhibition: an fMRI study
  179. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study
  180. Atlas Template Images for Nonhuman Primate Neuroimaging: Baboon and Macaque
  181. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET)
  182. Rapid intravenous loading of levodopa for human research: clinical results
  183. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease
  184. A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
  185. Psychiatric Neuroimaging Research
  186. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  187. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  188. Template Images for Nonhuman Primate Neuroimaging: 2. Macaque
  189. Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
  190. Dopa-Induced Blood Flow Responses in Nonhuman Primates
  191. Response to levodopa challenge in Tourette syndrome
  192. Neuropsychiatry of movement disorders
  193. On the efficiency of stereologic volumetry as commonly implemented for three-dimensional digital images
  194. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm
  195. Altered thalamic response to levodopa in Parkinson’s patients with dopa-induced dyskinesias
  196. Putamen volume in idiopathic focal dystonia
  197. Preventing contractures in NMS and dystonia
  198. MPTP induces dystonia and parkinsonism
  199. Baboon Basal Ganglia Stereotaxy Using Internal MRI Landmarks: Validation and Application to PET Imaging
  200. Personality disorder scores improve with effective pharmacotherapy of depression
  201. Stereological MRI volumetry of the frontal lobe
  202. A Metric for Testing the Accuracy of Cross-Modality Image Registration: Validation and Application
  203. The Dexamethasone Suppression Test for Diagnosing Depression in Stroke Patients
  204. Anosognosia for Depressive Signs
  205. Diagnosing Depression After Stroke
  206. Platelet Binding Characteristics Distinguish Placebo Responders from Nonresponders in Depression
  207. MRI volumetry of prefrontal cortex
  208. Hippocampal MR volumetry
  209. Severe Imipramine-Induced Myoclonus in a Patient with Psychotic Bipolar Depression, Catatonia, and Schizencephaly
  210. Subcortical brain anatomy in anorexia and bulimia
  211. Faculty of 1000 evaluation for Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
  212. TicTimer software for measuring tic suppression
  213. “But my department chair wants big-name journals”: Gentle steps to open publishing
  214. Software for web-based tic suppression training
  215. Tics
  216. Treatment of Parkinson’s disease psychosis
  217. Tourette syndrome research highlights from 2016
  218. BillCorrectly: A software tool to help psychiatrists bill E&M codes appropriately
  219. Suggestions for new NIH grant applicants